Pediatric Respiratory and Sleep Medicine Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Pediatric Respiratory and Sleep Medicine Research Center, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
Immun Inflamm Dis. 2024 Nov;12(11):e70049. doi: 10.1002/iid3.70049.
The pediatric community is considered a suitable target for controlling the spread and mortality of viral diseases. In late December 2019, a respiratory disease due to the novel coronavirus, later COVID-19, hit the globe. The COVID-19 global disruption had direct and indirect impacts on different aspects of child health. Therefore, surveillance, preventive approaches, and treatment plans for children came into the spotlight.
This study aims to discuss the clinical pictures as well as laboratory and radiological findings of the infected children during the COVID-19 pandemic. The focus of this study is to express the clinical manifestations of respiratory disease in pediatric SARS-CoV-2, available therapeutic options, vaccine recommendations, and long COVID sequelae in affected children. This review could serve as a hint for upcoming challenges in pediatric care during future pandemics.
The clinical presentation of COVID-19 in pediatrics can range from mild pulmonary disease to acute respiratory distress syndrome (ARDS). Supportive care is a crucial component of the management of pediatric COVID-19. However, the importance of specializing in how to treat patients with more severe conditions cannot be overstated. Additionally, clinicians must consider prevention strategies as well as potential complications.
Although the infected patients are dipping day by day, there is a lack of clinical guidelines for pediatric SARS-CoV-2-associated pulmonary diseases. Understanding of the physicians about all aspects of pediatric care during the COVID-19 pandemic could lead to enhanced quality of future patient care and safety, reduced costs of health policies, and surveil the risk that patients with respiratory viruses can expose to society.
儿科领域被认为是控制病毒疾病传播和死亡率的合适目标。2019 年 12 月底，一种新型冠状病毒引起的呼吸道疾病，即后来的 COVID-19，席卷全球。COVID-19 的全球大流行对儿童健康的各个方面都产生了直接和间接的影响。因此，针对儿童的监测、预防措施和治疗计划成为了焦点。
本研究旨在讨论 COVID-19 大流行期间感染儿童的临床特征以及实验室和影像学发现。本研究的重点是表达儿童 SARS-CoV-2 呼吸道疾病的临床表现、现有的治疗选择、疫苗建议以及受影响儿童的长期 COVID 后遗症。这篇综述可以为未来儿科护理在未来大流行期间面临的挑战提供线索。
COVID-19 在儿科的临床表现范围从轻度肺部疾病到急性呼吸窘迫综合征（ARDS）。支持性护理是儿童 COVID-19 管理的重要组成部分。然而，强调专门治疗更严重病情的重要性也不过分。此外，临床医生必须考虑预防策略以及潜在的并发症。
尽管感染人数在逐日减少，但针对儿童 SARS-CoV-2 相关肺部疾病仍缺乏临床指南。医生对 COVID-19 大流行期间儿科护理各个方面的理解可以提高未来患者护理的质量和安全性，降低卫生政策的成本，并监测呼吸道病毒患者对社会的风险。
